125 related articles for article (PubMed ID: 28024722)
1. The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma.
Martel M; Alemany L; Taberna M; Mena M; Tous S; Bagué S; Castellsagué X; Quer M; León X
Oral Oncol; 2017 Jan; 64():37-43. PubMed ID: 28024722
[TBL] [Abstract][Full Text] [Related]
2. Double positivity for HPV-DNA/p16
Mena M; Taberna M; Tous S; Marquez S; Clavero O; Quiros B; Lloveras B; Alejo M; Leon X; Quer M; Bagué S; Mesia R; Nogués J; Gomà M; Aguila A; Bonfill T; Blazquez C; Guix M; Hijano R; Torres M; Holzinger D; Pawlita M; Pavon MA; Bravo IG; de Sanjosé S; Bosch FX; Alemany L
Oral Oncol; 2018 Mar; 78():137-144. PubMed ID: 29496041
[TBL] [Abstract][Full Text] [Related]
3. Atypical clinical behavior of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy.
Huang SH; Perez-Ordonez B; Liu FF; Waldron J; Ringash J; Irish J; Cummings B; Siu LL; Kim J; Weinreb I; Hope A; Gullane P; Brown D; Shi W; O'Sullivan B
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):276-83. PubMed ID: 20950953
[TBL] [Abstract][Full Text] [Related]
4. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study.
Milliet F; Bozec A; Schiappa R; Viotti J; Modesto A; Dassonville O; Poissonnet G; Guelfucci B; Bizeau A; Vergez S; Dupret-Bories A; Garrel R; Fakhry N; Santini L; Lallemant B; Chambon G; Sudaka A; Peyrade F; Saada-Bouzid E; Benezery K; Jourdan-Soulier F; Chapel F; Sophie Ramay A; Roger P; Galissier T; Coste V; Ben Lakdar A; Guerlain J; Temam S; Mirghani H; Gorphe P; Chamorey E; Culié D
Oral Oncol; 2021 Jan; 112():105041. PubMed ID: 33129057
[TBL] [Abstract][Full Text] [Related]
5. HPV driven squamous cell head and neck cancer of unknown primary is likely to be HPV driven squamous cell oropharyngeal cancer.
Schroeder L; Pring M; Ingarfield K; Pawlita M; Leary SD; Thomas SJ; Waylen A; Waterboer T; Ness AR
Oral Oncol; 2020 Aug; 107():104721. PubMed ID: 32361566
[TBL] [Abstract][Full Text] [Related]
6. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
[TBL] [Abstract][Full Text] [Related]
7. Rising incidence of HPV positive oropharyngeal cancer in Taiwan between 1999 and 2014 where betel nut chewing is common.
Wang CP; Chen TC; Hsu WL; Hsiao JR; Chen PR; Chen MK; Hua CH; Tsai MH; Ko JY; Lou PJ; Chiang CJ; Wu CT; Chang YL
BMC Cancer; 2022 Mar; 22(1):296. PubMed ID: 35313837
[TBL] [Abstract][Full Text] [Related]
8. Deintensification candidate subgroups in human papillomavirus-related oropharyngeal cancer according to minimal risk of distant metastasis.
O'Sullivan B; Huang SH; Siu LL; Waldron J; Zhao H; Perez-Ordonez B; Weinreb I; Kim J; Ringash J; Bayley A; Dawson LA; Hope A; Cho J; Irish J; Gilbert R; Gullane P; Hui A; Liu FF; Chen E; Xu W
J Clin Oncol; 2013 Feb; 31(5):543-50. PubMed ID: 23295795
[TBL] [Abstract][Full Text] [Related]
9. Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database.
Rettig EM; Zaidi M; Faraji F; Eisele DW; El Asmar M; Fung N; D'Souza G; Fakhry C
Oral Oncol; 2018 Aug; 83():147-153. PubMed ID: 30098771
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic characteristics of patients with oropharyngeal carcinoma according to tumor HPV status, patient smoking status, and sexual behavior.
Dahlstrom KR; Bell D; Hanby D; Li G; Wang LE; Wei Q; Williams MD; Sturgis EM
Oral Oncol; 2015 Sep; 51(9):832-8. PubMed ID: 26120093
[TBL] [Abstract][Full Text] [Related]
11. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
[TBL] [Abstract][Full Text] [Related]
12. Diagnosis of HPV driven oropharyngeal cancers: Comparing p16 based algorithms with the RNAscope HPV-test.
Mirghani H; Casiraghi O; Guerlain J; Amen F; He MX; Ma XJ; Luo Y; Mourareau C; Drusch F; Lakdhar AB; Melkane A; St Guily L; Badoual C; Scoazec JY; Borget I; Aupérin A; Dalstein V; Vielh P
Oral Oncol; 2016 Nov; 62():101-108. PubMed ID: 27865361
[TBL] [Abstract][Full Text] [Related]
13. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer.
Yoshida H; Murono S; Ueno T; Nakanishi Y; Tsuji A; Hatano M; Endo K; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
Acta Otolaryngol; 2017 Jul; 137(7):773-777. PubMed ID: 28093931
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus (HPV) 16 antibodies at diagnosis of HPV-related oropharyngeal cancer and antibody trajectories after treatment.
Zhang Y; Waterboer T; Haddad RI; Miles BA; Wentz A; Gross ND; Fakhry C; Quon H; Lorch JH; Gourin CG; Clayburgh D; Misiukiewicz KJ; Richmon JD; Andersen PE; Posner MR; D'Souza G
Oral Oncol; 2017 Apr; 67():77-82. PubMed ID: 28351584
[TBL] [Abstract][Full Text] [Related]
16. High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma.
Licitra L; Perrone F; Bossi P; Suardi S; Mariani L; Artusi R; Oggionni M; Rossini C; Cantù G; Squadrelli M; Quattrone P; Locati LD; Bergamini C; Olmi P; Pierotti MA; Pilotti S
J Clin Oncol; 2006 Dec; 24(36):5630-6. PubMed ID: 17179101
[TBL] [Abstract][Full Text] [Related]
17. The changing incidence of human papillomavirus-associated oropharyngeal cancer using multiple imputation from 2000 to 2010 at a Comprehensive Cancer Centre.
Habbous S; Chu KP; Qiu X; La Delfa A; Harland LT; Fadhel E; Hui A; Perez-Ordonez B; Weinreb I; Liu FF; Waldron J; O'Sullivan B; Goldstein D; Xu W; Huang SH; Liu G
Cancer Epidemiol; 2013 Dec; 37(6):820-9. PubMed ID: 24184275
[TBL] [Abstract][Full Text] [Related]
18. Proposed Staging System for Patients With HPV-Related Oropharyngeal Cancer Based on Nasopharyngeal Cancer N Categories.
Dahlstrom KR; Garden AS; William WN; Lim MY; Sturgis EM
J Clin Oncol; 2016 Jun; 34(16):1848-54. PubMed ID: 26884553
[TBL] [Abstract][Full Text] [Related]
19. Epithelial to mesenchymal transition and HPV infection in squamous cell oropharyngeal carcinomas: the papillophar study.
Lefevre M; Rousseau A; Rayon T; Dalstein V; Clavel C; Beby-Defaux A; Pretet JL; Soussan P; Polette M; Lacau Saint Guily J; Birembaut P;
Br J Cancer; 2017 Jan; 116(3):362-369. PubMed ID: 28072763
[TBL] [Abstract][Full Text] [Related]
20. Oropharyngeal cancer prognosis by tumour HPV status in France: The multicentric Papillophar study.
Lacau St Guily J; Rousseau A; Baujat B; Périé S; Schultz P; Barry B; Dufour X; Malard O; Pretet JL; Clavel C; Birembaut P; Franceschi S;
Oral Oncol; 2017 Apr; 67():29-36. PubMed ID: 28351578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
